Release 4B Ballot #1

This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0304

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Device, Encounter, Patient, Practitioner, RelatedPerson

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationAdministration.

Generated Narrative

status: completed

medication:

code: Alemtuzumab 10mg/ml (Lemtrada)

subject: Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male

context: encounter who leads to this prescription. Generated Summary: id: v1451 (OFFICIAL); status: finished; ambulatory; Patient-initiated encounter; Non-urgent cardiological admission; Heart valve replacement

effective: 15 Jan. 2015, 2:30:00 pm --> 16 Jan. 2015, 12:30:00 am

Performers

-Actor
*Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07

reasonReference: Generated Summary: Resolved; Confirmed; Encounter Diagnosis; Severe; Malignant neoplastic disease; Entire head and neck; 52 years; 54 years; recordedDate: 2012-12-01

request: Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; Piperacillin/Tazobactam 4.5gm; authoredOn: 2015-01-15; Community acquired pneumonia (disorder)

Dosages

-TextRouteMethodDose
*Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wkIntravenous route (qualifier value)Inject - dosing instruction imperative (qualifier value)3 mg

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.